{"corpus_id":19816415,"paper_sha":"e63937184c8bc856924c06a7c584c8c48c573fc8","doi":"10.1001/ARCHOPHT.122.4.477","arxiv_id":null,"pmid":15078664,"pmcid":null,"mag_id":1789824814,"dblp_id":null,"acl_id":null,"title":"Causes and prevalence of visual impairment among adults in the United States.","year":2004,"publication_date":"2004-04-01","venue":"A M A Archives of Ophthalmology","journal":{"name":"Archives of ophthalmology","pages":"\n          477-85\n        ","volume":"122 4"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle","Study"],"pubmed_pub_types":["Comparative Study","Journal Article","Research Support, Non-U.S. Gov't","Research Support, U.S. Gov't, P.H.S."],"s2_fields_of_study":["Medicine"],"reference_count":34,"citation_count":2635,"influential_citation_count":95,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Adult","mj":false,"ui":"D000328"},{"d":"Black or African American","mj":false,"qs":[{"q":"statistics & numerical data","mj":true,"ui":"Q000706"}],"ui":"D001741"},{"d":"Age Distribution","mj":false,"ui":"D017677"},{"d":"Aged","mj":false,"ui":"D000368"},{"d":"Aged, 80 and over","mj":false,"ui":"D000369"},{"d":"Australia","mj":false,"qs":[{"q":"epidemiology","mj":false,"ui":"Q000453"}],"ui":"D001315"},{"d":"Blindness","mj":false,"qs":[{"q":"ethnology","mj":true,"ui":"Q000208"},{"q":"etiology","mj":false,"ui":"Q000209"}],"ui":"D001766"},{"d":"Cataract","mj":false,"qs":[{"q":"complications","mj":false,"ui":"Q000150"},{"q":"epidemiology","mj":false,"ui":"Q000453"}],"ui":"D002386"},{"d":"Causality","mj":false,"ui":"D015984"},{"d":"Europe","mj":false,"qs":[{"q":"epidemiology","mj":false,"ui":"Q000453"}],"ui":"D005060"},{"d":"Female","mj":false,"ui":"D005260"},{"d":"Glaucoma","mj":false,"qs":[{"q":"complications","mj":false,"ui":"Q000150"},{"q":"epidemiology","mj":false,"ui":"Q000453"}],"ui":"D005901"},{"d":"Hispanic or Latino","mj":false,"qs":[{"q":"statistics & numerical data","mj":true,"ui":"Q000706"}],"ui":"D006630"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Macular Degeneration","mj":false,"qs":[{"q":"complications","mj":false,"ui":"Q000150"},{"q":"epidemiology","mj":false,"ui":"Q000453"}],"ui":"D008268"},{"d":"Male","mj":false,"ui":"D008297"},{"d":"Middle Aged","mj":false,"ui":"D008875"},{"d":"Prevalence","mj":false,"ui":"D015995"},{"d":"United States","mj":false,"qs":[{"q":"epidemiology","mj":false,"ui":"Q000453"}],"ui":"D014481"},{"d":"Vision, Low","mj":false,"qs":[{"q":"ethnology","mj":true,"ui":"Q000208"},{"q":"etiology","mj":false,"ui":"Q000209"}],"ui":"D015354"},{"d":"Visual Acuity","mj":false,"ui":"D014792"},{"d":"Persons with Visual Disabilities","mj":false,"qs":[{"q":"statistics & numerical data","mj":true,"ui":"Q000706"}],"ui":"D019987"},{"d":"White People","mj":false,"qs":[{"q":"statistics & numerical data","mj":true,"ui":"Q000706"}],"ui":"D044465"}],"chemicals":null,"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://jamanetwork.com/journals/jamaophthalmology/articlepdf/416228/eeb30081_477_485.pdf","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/e63937184c8bc856924c06a7c584c8c48c573fc8","s2_open_access_license":null,"s2_open_access_status":"BRONZE","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"OBJECTIVES: To estimate the cause-specific prevalence and distribution of blindness and low vision in the United States by age, race/ethnicity, and gender, and to estimate the change in these prevalence figures over the next 20 years. METHODS: Summary prevalence estimates of blindness (both according to the US definition of < or =6/60 [< or =20/200] best-corrected visual acuity in the better-seeing eye and the World Health Organization standard of < 6/120 [< 20/400]) and low vision (< 6/12 [< 20/40] best-corrected vision in the better-seeing eye) were prepared separately for black, Hispanic, and white persons in 5-year age intervals starting at 40 years. The estimated prevalences were based on recent population-based studies in the United States, Australia, and Europe. These estimates were applied to 2000 US Census data, and to projected US population figures for 2020, to estimate the number of Americans with visual impairment. Cause-specific prevalences of blindness and low vision were also estimated for the different racial/ethnic groups. RESULTS: Based on demographics from the 2000 US Census, an estimated 937 000 (0.78%) Americans older than 40 years were blind (US definition). An additional 2.4 million Americans (1.98%) had low vision. The leading cause of blindness among white persons was age-related macular degeneration (54.4% of the cases), while among black persons, cataract and glaucoma accounted for more than 60% of blindness. Cataract was the leading cause of low vision, responsible for approximately 50% of bilateral vision worse than 6/12 (20/40) among white, black, and Hispanic persons. The number of blind persons in the US is projected to increase by 70% to 1.6 million by 2020, with a similar rise projected for low vision. CONCLUSIONS: Blindness or low vision affects approximately 1 in 28 Americans older than 40 years. The specific causes of visual impairment, and especially blindness, vary greatly by race/ethnicity. The prevalence of visual disabilities will increase markedly during the next 20 years, owing largely to the aging of the US population.","claims":[{"public_id":"cl_07457e000d9f3d6226abfbf5826502ea","status":"active","text":"Age-related macular degeneration was the leading cause of blindness among white persons, while cataract and glaucoma accounted for more than 60% of blindness among black persons.","confidence":0.97,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_07457e000d9f3d6226abfbf5826502ea"},{"public_id":"cl_72f49bb3348a2a56778067b8fa4a7031","status":"active","text":"An estimated 937,000 Americans older than 40 years were blind by the US definition, and an additional 2.4 million had low vision based on the 2000 US Census population.","confidence":0.98,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_72f49bb3348a2a56778067b8fa4a7031"},{"public_id":"cl_164fc5893453ef04c13b55f42e1b7b44","status":"active","text":"Blindness or low vision affects approximately 1 in 28 Americans older than 40 years, and the causes of visual impairment vary greatly by race/ethnicity.","confidence":0.94,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_164fc5893453ef04c13b55f42e1b7b44"},{"public_id":"cl_638ff92db650c46728adb6f6f8810b5a","status":"active","text":"Cataract was the leading cause of low vision, responsible for approximately 50% of bilateral vision worse than 6/12 among white, black, and Hispanic persons.","confidence":0.96,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_638ff92db650c46728adb6f6f8810b5a"},{"public_id":"cl_d8aa8e155458fa7cec40db8b1b0485c9","status":"active","text":"The number of blind persons in the United States is projected to increase by 70% to 1.6 million by 2020, with a similar rise projected for low vision.","confidence":0.97,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_d8aa8e155458fa7cec40db8b1b0485c9"}],"concepts":[{"public_id":"co_009c49fc092cbee325e6a792d65a17e3","status":"active","name":"2000 US Census","description":"The United States census population counts for the year 2000 used to scale prevalence estimates.","types":["population dataset"],"aliases":["2000 Census"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_009c49fc092cbee325e6a792d65a17e3"},{"public_id":"co_01be9666a06d3d1be7ecd4ffcfad7052","status":"active","name":"race/ethnicity","description":"A grouping variable used to compare prevalence and causes of visual impairment across racial and ethnic populations.","types":["demographic variable"],"aliases":["racial/ethnic group"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_01be9666a06d3d1be7ecd4ffcfad7052"},{"public_id":"co_6a0f29e2d8ba94859686c409a18c6f72","status":"active","name":"2020 projected US population","description":"Projected United States population figures for the year 2020 used to estimate future visual impairment counts.","types":["population projection"],"aliases":["projected US population for 2020"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_6a0f29e2d8ba94859686c409a18c6f72"},{"public_id":"co_83a954c4aa25811435396a0782aa848a","status":"active","name":"cataract","description":"Opacity of the eye's lens that can reduce visual acuity and cause visual impairment.","types":["cause of visual impairment"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_83a954c4aa25811435396a0782aa848a"},{"public_id":"co_88dc0d5ab45a1b4a2248235a3ceca5fa","status":"active","name":"glaucoma","description":"A group of eye diseases that damage the optic nerve and can lead to blindness.","types":["cause of blindness"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_88dc0d5ab45a1b4a2248235a3ceca5fa"},{"public_id":"co_936ce97f788a1ce2c9c61cb65b69ca99","status":"active","name":"white persons","description":"Individuals identified as White in the study's racial/ethnic group comparisons.","types":["population group"],"aliases":["white"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_936ce97f788a1ce2c9c61cb65b69ca99"},{"public_id":"co_94189c4327145b165c5c4d59362b981d","status":"active","name":"age-related macular degeneration","description":"A degenerative retinal disease affecting the macula and a major cause of visual loss in older adults.","types":["cause of blindness"],"aliases":["AMD"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_94189c4327145b165c5c4d59362b981d"},{"public_id":"co_ad1145894c015c3ca20cecfbedb3767c","status":"active","name":"black persons","description":"Individuals identified as Black in the study's racial/ethnic group comparisons.","types":["population group"],"aliases":["black"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_ad1145894c015c3ca20cecfbedb3767c"},{"public_id":"co_b0302a1908fbb6cdd829e3c5c4cbb4df","status":"active","name":"Hispanic persons","description":"Individuals identified as Hispanic in the study's racial/ethnic group comparisons.","types":["population group"],"aliases":["Hispanic"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_b0302a1908fbb6cdd829e3c5c4cbb4df"},{"public_id":"co_b595f462acb855ac92814f20ad95c73d","status":"active","name":"low vision","description":"Reduced visual acuity defined here as better-corrected vision worse than 6/12 (20/40) in the better-seeing eye.","types":["condition"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_b595f462acb855ac92814f20ad95c73d"},{"public_id":"co_ba0b602c3aa8d20f50724757fae10d83","status":"active","name":"blindness","description":"Severe visual impairment defined here using the US threshold of 6/60 (20/200) or the World Health Organization threshold of 6/120 (20/400) best-corrected visual acuity in the better-seeing eye.","types":["condition"],"aliases":["blind"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_ba0b602c3aa8d20f50724757fae10d83"}],"external_ids":{"DOI":"10.1001/ARCHOPHT.122.4.477","ArXiv":null,"PubMed":15078664,"PubMedCentral":null,"MAG":1789824814,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://jamanetwork.com/journals/jamaophthalmology/articlepdf/416228/eeb30081_477_485.pdf","landing_url":"https://www.semanticscholar.org/paper/e63937184c8bc856924c06a7c584c8c48c573fc8","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":null,"status":"BRONZE","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":631465,"paper_uid":"9a5001cc-ca80-450d-a076-b0d1dca6bc9d","canonical_identity":{"paper_id":631465,"paper_uid":"9a5001cc-ca80-450d-a076-b0d1dca6bc9d","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/19816415"}